The burden of stress in head and neck cancer

Psycho-Oncology

Volumn 22, Issue 3, 2013, Pages 668-676

  Devins, Gerald M ^a,b   Payne, Ada Y M ^b   Lebel, Sophie ^c   Mah, Kenneth ^a   Lee, Ruth N F ^d,e   Irish, Jonathan ^a,b,f   Wong, Janice ^b   Rodin, Gary M ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

^e MCMASTER UNIVERSITY   (Canada)

^f CANCER CARE ONTARIO   (Canada)

Author keywords

depressive symptoms; head and neck cancer; life stress; lifestyle; medical; psychology; quality of life; screening

Indexed keywords

ADULT; ARTICLE; CANCER RELATED STRESSORS CHECKLIST; CANCER SURVIVOR; CHECKLIST; DAILY LIFE ACTIVITY; DISTRESS SYNDROME; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERPERSONAL STRESS; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; SELF REPORT; SOCIAL PSYCHOLOGY; STRESS;

COST OF ILLNESS; DEPRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; STRESS, PSYCHOLOGICAL;

EID: 84874723291     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3050     Document Type: Article

References (63)

1. National Cancer Institute. SEER Stat Fact Sheets. http://seer.cancer.gov/ statfacts/html/all.html, US National Cancer Institute Surveillance Epidemiology and End Results, 2008.
2. Devins GM, Otto KJ, Irish JC, Rodin GM,. Head and neck cancer. In Psycho-Oncology, Holland JC, Breitbart WS, Jacobsen PB, Lederberg MS, Loscalzo MJ, McCorkle R, (eds). Oxford University Press: New York, 2010; 135-139.
3. Dirix P, Nuyts S, Vander Poorten P, Delaere P, Van den Bogaert W,. The influence of xerostomia after radiotherapy on quality of life: results of a questionnaire in head and neck cancer. Support Care Cancer 2008; 16 (2): 171-179.
4. Duncan GG, Epstein JB, Tu D, et al,. Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 2005; 27 (5): 421-428.
5. Hagedoorn M, Molleman E,. Facial disfigurement in patients with head and neck cancer: the role of social self-efficacy. Health Psychol 2006; 25 (5): 643-647.
6. Muller R, Paneff J, Kollner V, Koch R,. Quality of life of patients with laryngeal carcinoma: a post-treatment study. Eur Arch Otorhinolaryngol 2001; 258 (6): 276-280.
7. Berger AM, Parker KP, Young-McCaughan S, et al,. Sleep wake disturbances in people with cancer and their caregivers: state of the science. Oncol Nurs Forum 2005; 32 (6): E98-E126.
8. Palme CE, Irish JC, Gullane PJ, Katz MR, Devins GM, Bachar G,. Quality of life analysis in patients with anterior skull base neoplasms. Head Neck 2009; 31: 1326-1334.
9. Duke RL, Campbell BH, Indresano AT, et al,. Dental status and quality of life in long-term head and neck cancer survivors. Laryngoscope 2005; 115 (4): 678-183.
10. Costa Bandeira AK, Azevedo EH, Vartanian JG, Nishimoto IN, Kowalski LP, Carrara-de Angelis E,. Quality of life related to swallowing after tongue cancer treatment. Dysphagia 2008; 23 (2): 183-192.
11. Kandogan T, Sanal A,. Quality of life, functional outcome, and voice handicap index in partial laryngectomy patients for early glottic cancer. BMC Ear Nose Throat Disord 2005; 5 (1): 3.
12. Chaukar DA, Walvekar RR, Das AK, et al,. Quality of life in head and neck cancer survivors: a cross-sectional survey. Am J Otolaryngol 2009; 30 (3): 176-180.
13. Lebel S, Devins GM,. Stigma in cancer patients whose behavior may have contributed to their disease. Future Oncol 2008; 4 (5): 717-733.
14. Henry DH, Viswanathan HN, Elkin EP, Traina S, Wade S, Cella D,. Symptoms and treatment burden associated with cancer treatment: results from a cross-sectional national survey in the U.S. Support Care Cancer 2008; 16 (7): 791-801.
15. Rapoport Y, Kreitler S, Chaitchik S, Algor R, Weissler K,. Psychosocial problems in head-and-neck cancer patients and their change with time since diagnosis. Ann Oncol 1993; 4 (1): 69-73.
16. Devins GM, Bezjak A, Mah K, Loblaw DA, Gotowiec AP,. Context moderates illness-induced lifestyle disruptions across life domains: a test of the illness intrusiveness theoretical framework in six common cancers. Psycho-Oncology 2006; 15 (3): 221-233.
17. Llewellyn CD, McGurk M, Weinman J,. How satisfied are head and neck cancer (HNC) patients with the information they receive pre-treatment? Results from the satisfaction with cancer information profile (SCIP). Oral Oncol 2006; 42 (7): 726-734.
18. McQuellon RP, Hurt GJ,. The psychosocial impact of the diagnosis and treatment of laryngeal cancer. Otolaryngol Clin North Am 1997; 30 (2): 231-241.
19. Campbell BH, Marbella A, Layde PM,. Quality of life and recurrence concern in survivors of head and neck cancer. Laryngoscope 2000; 110: 895-906.
20. Karnell LH, Funk GF, Christensen AJ, Rosenthal EL, Magnuson JS,. Persistent posttreatment depressive symptoms in patients with head and neck cancer. Head Neck 2006; 28 (5): 453-461.
21. Mitchell AJ, Chan M, Bhatti H, et al,. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. Lancet Oncol 2011; 12 (2): 160-174.
22. Walker J, Waters RA, Murray G, et al,. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol 2008; 26 (10): 4725-4730.
23. Hem E, Loge JH, Haldorsen T, Ekeberg O,. Suicide risk in cancer patients from 1960 to 1999. J Clin Oncol 2004; 22 (20): 4209-4216.
24. Devlen J,. Psychological and social aspects of Hodgkin's disease and non-Hodgkin's lymphoma. University of Manchester, 1984.
25. Chaturvedi SK, Shenoy A, Prasad KM, Senthilnathan SM, Premlatha BS,. Concerns, coping and quality of life in head and neck cancer patients. Support Care Cancer 1996; 4 (3): 186-190.
26. Harrison J, Maguire P, Ibbotson T, Macleod R, Hopwood P,. Concerns, confiding and psychiatric disorder in newly diagnosed cancer patients: a descriptive study. Psycho-Oncology 1994; 3 (3): 173-179.
27. Gotay CC, Pagano IS,. Assessment of Survivor Concerns (ASC): a newly proposed brief questionnaire. Health Qual Life Outcomes 2007; 5 (15), DOI: 10.1186/477-7525-5-15.
28. Zebrack BJ, Ganz PA, Bernaards CA, Petersen L, Abram L,. Assessing the impact of cancer: development of a new instrument for long-term survivors. Psycho-Oncology 2006; 15 (5): 407-421.
29. Crespi CM, Ganz PA, Petersen L, Castillo A, Caan B,. Refinement and psychometric evaluation of the impact of cancer scale. J Natl Cancer Inst 2008; 100 (21): 1530-1541.
30. Feinstein AR,. Clinimetrics. Yale University Press: New Haven, CT, 1987.
31. Rumsey N, Clarke A, White P,. Exploring the psychosocial concerns of outpatients with disfiguring conditions. J Wound Care 2003; 12 (7): 247-252.
32. Sanson-Fisher R, Girgis A, Boyes A, Bonevski B, Burton L, Cook P,. The unmet supportive care needs of patients with cancer. Cancer 2000; 88 (1): 225-236.
33. Bonevski B, Sanson-Fisher R, Girgis A, Burton L, Cook P, Boyes A,. Evaluation of an instrument to assess the needs of patients with cancer. Cancer 2000; 88 (1): 217-225.
34. Devins GM,. Using the Illness Intrusiveness Ratings Scale to understand health-related quality of life in chronic disease. J Psychosom Res 2010; 68 (6): 591-602.
35. Devins GM,. Illness intrusiveness and the psychosocial impact of lifestyle disruptions in chronic life-threatening disease. Adv Ren Replace Ther 1994; 1 (3): 251-263.
36. Bultz BD, Carlson LE,. Emotional distress: the sixth vital sign in cancer care. J Clin Oncol 2005; 23 (26): 6440-6441.
37. Carlson LE, Bultz BD, Speca M, St-Pierre M,. Partners of cancer patients: part II. Current psychosocial interventions and suggestions for improvement. J Psychosoc Oncol 2000; 18 (3): 33-43.
38. NVivo qualitative data analysis software (version 7). QSR International Pty Ltd.: Victoria, Australia, 2006.
39. Devins GM, Binik YM, Hutchinson TA, Hollomby DJ, Barre PE, Guttmann RD,. The emotional impact of end-stage renal disease: importance of patients' perceptions of intrusiveness and control. Int J Psychiat Med 1983; 13 (4): 327-343.
40. Devins GM, Dion R, Pelletier LG, et al,. The structure of lifestyle disruptions in chronic disease: a confirmatory factor analysis of the Illness Intrusiveness Ratings Scale. Med Care 2001; 39: 1097-1104.
41. Mah K, Bezjak A, Loblaw DA, Gotowiec A, Devins GM,. Confirmatory factor analysis of the Illness Intrusiveness Ratings Scale's 3-factor structure in men and women with cancer: measurement invariance in men and women with cancer. Rehabil Psychol 2011; 56 (1): 58-66.
42. Radloff LS,. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Meas 1977; 3: 385-401.
43. Devins GM, Orme CM, Costello CG, et al,. Measuring depressive symptoms in illness populations: psychometric properties of the Center for Epidemiologic Studies Depression (CES-D) Scale. Psychol Health 1988; 2: 139-156.
44. Devins GM, Orme CM,. Center for epidemiologic studies depression scale. In Test Critiques, Keyser DJ, Sweetland RC, (eds). Test Corporation of America: Kansas, 1985; 144-160.
45. Beanlands HJ, Lipton JH, McCay EA, et al,. Self-concept as a "BMT patient", illness intrusiveness, and engulfment in allogeneic bone marrow transplant recipients. J Psychosom Res 2003; 55 (5): 419-425.
46. Portenoy RK, Thaler HT, Kornblith AB, et al,. The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 1994; 30A (9): 1326-1336.
47. Costello CG, Devins GM,. Screening for stressful life events and chronic difficulties. Can J Behav Sci 1988; 20: 85-92.
48. Bartholomew DJ, Steele FA, Moustaki IGJI,. Analysis of Multivariate Social Science Data (2nd edn). Chapman & Hall: London, 2008.
49. Hayes AF, Krippendorff K,. Answering the call for a standard reliability measure for coding data. Commun Methods Meas 2007; 1: 77-89.
50. Cohen J, Cohen P, West SG, Aiken LS,. Applied Multiple Regression/Correlation Analysis for the Behavioral Sciences (3rd edn). Lawrence Erlbaum Associates: Mahweh, NJ, 2003.
51. Myers DG,. The funds, friends, and faith of happy people. Am Psychol 2000; 55 (1): 56-67.
52. Abbott BB, Badia P,. Predictable versus unpredictable shock conditions and physiological measures of stress: a reply to Arthur. Psychol Bull 1986; 100 (3): 384-387.
53. Lebel S, Rosberger Z, Edgar L, Devins GM,. Comparison of four common stressors across the breast cancer trajectory. J Psychosom Res 2007; 63 (3): 225-232.
54. Armes J, Crowe M, Colbourne L, et al,. Patients' supportive care needs beyond the end of cancer treatment: a prospective, longitudinal survey. J Clin Oncol 2009; 27 (36): 6172-6179.
55. Devins GM, Stam HJ, Koopmans JP,. Psychosocial impact of laryngectomy mediated by perceived stigma and illness intrusiveness. Can J Psychiat 1994; 39 (10): 608-616.
56. Katz MR, Irish JC, Devins GM, Rodin GM, Gullane PJ,. Reliability and validity of an observer-rated disfigurement scale for head and neck cancer patients. Head Neck 2000; 22: 132-141.
57. Fife BL, Wright ER,. The dimensionality of stigma: a comparison of its impact on the self of persons with HIV/AIDS and cancer. J Health Soc Behav 2000; 41: 50-67.
58. Holland JC,. Societal views of cancer and the emergence of psycho-oncology. In Psycho-Oncology, Holland JC, (ed.). Oxford University Press: New York, 1998; 3-15.
59. Anastasi A,. Psychological Testing (6th edn). Macmillan: New York, 1988.
60. Campbell DT, Fiske DW,. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959; 56: 81-105.
61. Cohen P., A source of bias in longitudinal investigations of change. In Best Methods for the Analysis of Change: Recent Advances, Unanswered Questions, Future Directions, Collins LM, Horn JL, (eds). American Psychological Association: Washington, DC, 1991; 18-30.
62. van Scheppingen C, Schroevers MJ, Smink A, et al,. Does screening for distress efficiently uncover meetable unmet needs in cancer patients? Psycho-Oncology 2010; 20 (6): 655-663.
63. Coughlin SS,. Recall bias in epidemiologic studies. J Clin Epidemiol 1990; 43 (1): 87-91.